UCL Discovery Stage
UCL home » Library Services » Electronic resources » UCL Discovery Stage

Undifferentiated carcinoma with osteoclast-like giant cells of the pancreas: An individual participant data meta-analysis

Mylonakis, Adam; Driva, Tatiana S; Lykoudis, Panagis; Frountzas, Maximos; Machairas, Nikolaos; Tsapralis, Dimitrios; Toutouzas, Konstantinos G; (2024) Undifferentiated carcinoma with osteoclast-like giant cells of the pancreas: An individual participant data meta-analysis. Annals of Hepato-Biliary-Pancreatic Surgery , 28 (2) pp. 125-133. 10.14701/ahbps.23-161. Green open access

[thumbnail of Undifferentiated carcinoma with osteoclast-like giant cells of the pancreas An individual participant data meta-analysis.pdf]
Preview
Text
Undifferentiated carcinoma with osteoclast-like giant cells of the pancreas An individual participant data meta-analysis.pdf - Published Version

Download (4MB) | Preview

Abstract

Undifferentiated carcinoma with osteoclast-like giant cells (UC-OGCs) of the pancreas is a rare neoplasm that accounts for less than 1% of all pancreatic malignancies. The aim of this study was to review the literature regarding UC-OGC, and to highlight its biological behavior, clinicopathologic characteristics, prognosis, and therapeutic options. A systematic review of the literature in PubMed/Medline and Scopus databases was performed (last search October 31st, 2023) for articles concerning pancreatic UC-OGC in the adult population. Fifty-seven studies met the inclusion criteria, involving 69 patients with a male-to-female ratio of 1.1:1 and a mean age of 62.96. Main symptoms included abdominal pain (33.3%), jaundice (14.5%), weight loss (8.7%), while fourteen patients (20.3%) were asymptomatic. Surgical resection was performed in 88.4% of cases. Survival rates at one, three, and five years were 58%, 44.7%, and 37.3% respectively. Sex, age, size (cut-off of 4 cm), location, and adjuvant treatment did not significantly affect patient survival. UC-OGC of the pancreas is a rare subtype of undifferentiated pancreatic carcinoma with a better prognosis than conventional pancreatic ductal adenocarcinoma or undifferentiated carcinoma without giant cells. The establishment of a dedicated patient registry is imperative to further delineate the optimal treatment for this uncommon clinical entity.

Type: Article
Title: Undifferentiated carcinoma with osteoclast-like giant cells of the pancreas: An individual participant data meta-analysis
Location: Korea (South)
Open access status: An open access version is available from UCL Discovery
DOI: 10.14701/ahbps.23-161
Publisher version: http://dx.doi.org/10.14701/ahbps.23-161
Language: English
Additional information: © 2024 Annals of Hepato-Biliary-Pancreatic Surgery. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0).
Keywords: Carcinoma, Osteoclast-like giant cells, Pancreas, Undifferentiated
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Surgery and Interventional Sci
URI: https://discovery-pp.ucl.ac.uk/id/eprint/10194941
Downloads since deposit
48Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item